Radiance to start RAPID (Radiation After PTA is Done) RDX trial:
This article was originally published in Clinica
Radiance Medical Systems is to begin a clinical trial in the US to assess its RDX radiation delivery system as a means of preventing restenosis in the peripheral vasculature. The RAPID (Radiation After PTA is Done) trial is part of an international study, already underway in Europe, designed to enrol up to 50 patients. The RDX system will be used to treat the superficial femoral artery, popliteal arteries and the primary arteries of the middle and lower leg. The study will include both de novo and in-stent lesion, says the Irvine, California firm.
You may also be interested in...
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.